Loratadine chemical structure
Find information on thousands of medical conditions and prescription drugs.

Loratadine

Loratadine is a drug used to treat allergies. It is marketed by Schering-Plough under several trade names such as Claritin®, Clarityn® or Claratyne® depending on the market, and by Wyeth as Alavert. It is also available as a generic. Its active metabolite, desloratadine, is also on the market, though loratadine itself is the only drug of its class available over the counter (at least in the US and UK) as of 2005. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

It is sometimes combined with pseudoephedrine to add a decongestant aspect to the treatment, making it somewhat useful for colds as well as allergies.

Available forms

Loratadine is available as tablets and oral suspension, and also in combination with pseudoephedrine. Also available are quick-dissolving tablets, which are advertised as being faster to get into one's system but which require special handling to avoid degrading in the package.

Mechanism of action

Loratadine is a tricyclic antihistamine, which has a selective and peripheral H1-antagonist action. It has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.

Pharmacokinetics

Loratadine is rapidly absorbed from the gastro-intestinal tract and it has rapid first-pass hepatic metabolism. Loratadine is almost totally bound to plasma proteins. Its metabolite, desloratadine (descarboethoxyloratadine), is also active, but binds to plasma proteins only moderately. The half-life of loratadine is on average 8 hours, and its metabolites 28 hours. About 40% is excreted as conjugated metabolites into the urine and similar amount into the feces. Traces of unmetabolised loratadine can be found in the urine.

Recommended dosage

  • Adults and children 15+ years: 10mg once every 24 hours.
  • Children 2-14 years:
    • Bodyweight above 30kg: 10mg once every 24 hours.
    • Bodyweight below 30kg: 5mg once every 24 hours.

(From product packaging for Clarityn tablets.)

Side-effects

Most common side-effects are fatigue, drowsiness, dry mouth, headache, and gastrointestinal disturbances.

Loratadine vs. desloratadine

A November 2003 article published in the journal American Family Physician about the safety, tolerability, effectiveness, price, and simplicity of desloratadine concluded the following:

Desloratadine is similar in effectiveness to fexofenadine and would be expected to produce results similar to loratadine and other nonsedating antihistamines.Thus Desloratidine is of faster onset of action than Loratidine as the Loratidine is activated in the liver into Desloratidine (which was introduced into the american market under the name Aerius by Schering Plough corporation). However, it may be an option for patients whose medical insurance no longer covers loratadine if the co-pay is less than the cost of the over-the-counter product.

External links and references

  • Desloratadine for Allergic Rhinitis, a November 2003 article from American Family Physician
  • Packaging directions in PDF Format. Product Packaging for Claritin 24 hour tablets. URL accessed on January 3, 2005.


Read more at Wikipedia.org


[List your site here Free!]


Loratadine/pseudoephedrin e for nasal symptons in seasonal allergic rhinitis: A double-blind, placebo-controlled study : An article from: Ear, Nose & Throat Journal $20.00 Loratadine makes switch to over-the-counter drug. (FDA Approves Status Change).(Brief Article) : An article from: Family Practice News $5.95
Over-the-counter status sought by maker of Claritin. (Clinical Rounds: Availability by end of 2002).(Schering-Plough Corp.)(Brief Article) : An article from: Internal Medicine News $5.95

OTC loratadine lifts allergy relief sales
Judging from the sheer dollars generated by sales of OTC loratadine products last year, there seem to be quite a lot of people willing to part with $20 every month for allergy relief. Indeed, betwe
Evaluation of an association between loratadine and hypospadias—United States, 1997-2001
Hypospadias is a birth defect that affects approximately seven in 1,000 male infants in the United States. In affected infants, the urethral opening ...
Aetna last month announced a program to provide approximately 475,000 of its commercial members with information about over-the-counter - Supplier News
Aetna last month announced a program to provide approximately 475,000 of its commercial members with information about over-the-counter, non-sedating ...
OTC loratadine products - What's Hot - over-the-counter - Brief Article
Claritin took center stage last month along OTC aisles, hitting retail shelves during the Christmas-shopping frenzy. In the first week, stores were peppered with Claritin signage enticing consumers
Loratadine remedies top list of hot OTC sales prospects - OTC/Natural Health - from Novartis
Loratadine remedies top list of hot OTC sales prospects. (OTC/Natural Health).(from Novartis)
Loratadine and hypospadias
Loratadine, available as Claritin since 1993 and now available in several generic and over-the-counter formulations, is a popular nonsedating antihistamine ...
Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: A double-blind, placebo-controlled study
Abstract In this double-blind, placebo-controlled, crossover, parallel study, we treated 20 adults who had seasonal allergic rhinitis with once-daily ...
Schering-Plough goes to court to protect loratadine patent - OTC/Natural Health Category News - Claritin - Brief Article
Schering-Plough goes to court to protect loratadine patent. (OTC/Natural Health Category News).(Claritin)

Home Contact Resources Exchange Links ebay